GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 208 filers reported holding GENMAB A/S in Q4 2021. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,686,279 | -10.9% | 104,516 | -3.9% | 0.65% | -9.1% |
| Q2 2023 | $4,135,184 | -1.2% | 108,792 | -1.8% | 0.72% | -4.8% |
| Q1 2023 | $4,184,072 | -23.2% | 110,807 | -13.8% | 0.75% | -23.4% |
| Q4 2022 | $5,448,542 | +29.0% | 128,564 | -2.2% | 0.98% | +16.6% |
| Q3 2022 | $4,223,000 | -1.3% | 131,430 | -0.2% | 0.84% | +3.1% |
| Q2 2022 | $4,279,000 | -11.2% | 131,708 | -1.1% | 0.82% | +5.6% |
| Q1 2022 | $4,818,000 | -12.6% | 133,172 | -4.5% | 0.77% | -4.9% |
| Q4 2021 | $5,514,000 | -13.4% | 139,390 | -4.3% | 0.81% | -16.5% |
| Q3 2021 | $6,367,000 | +6.2% | 145,698 | -0.7% | 0.97% | +10.6% |
| Q2 2021 | $5,993,000 | +24.8% | 146,774 | +0.4% | 0.88% | +17.3% |
| Q1 2021 | $4,802,000 | -18.7% | 146,261 | +0.7% | 0.75% | -22.8% |
| Q4 2020 | $5,904,000 | +6.5% | 145,198 | -4.1% | 0.97% | -4.4% |
| Q3 2020 | $5,545,000 | +4.4% | 151,464 | -3.3% | 1.02% | +1.8% |
| Q2 2020 | $5,309,000 | +39.6% | 156,640 | -12.7% | 1.00% | +19.0% |
| Q1 2020 | $3,802,000 | +6.5% | 179,426 | +12.2% | 0.84% | +36.6% |
| Q4 2019 | $3,571,000 | -74.8% | 159,919 | -77.1% | 0.62% | -60.1% |
| Q3 2019 | $14,169,000 | +12.3% | 699,340 | +2.4% | 1.54% | +17.7% |
| Q2 2019 | $12,616,000 | +1.1% | 682,924 | -4.5% | 1.31% | -0.4% |
| Q1 2019 | $12,474,000 | +1242.7% | 715,259 | +1169.0% | 1.32% | +1096.4% |
| Q4 2018 | $929,000 | +7.4% | 56,364 | +2.6% | 0.11% | +27.9% |
| Q3 2018 | $865,000 | +6.7% | 54,924 | +3.8% | 0.09% | +1.2% |
| Q2 2018 | $811,000 | -14.5% | 52,933 | +504.8% | 0.08% | -13.3% |
| Q1 2018 | $949,000 | +56.9% | 8,752 | +19.8% | 0.10% | +63.3% |
| Q4 2017 | $605,000 | +17.0% | 7,305 | +56.4% | 0.06% | +17.6% |
| Q3 2017 | $517,000 | +4.4% | 4,672 | +0.8% | 0.05% | -1.9% |
| Q2 2017 | $495,000 | +8.1% | 4,633 | -2.1% | 0.05% | +8.3% |
| Q1 2017 | $458,000 | -45.6% | 4,731 | -53.4% | 0.05% | -46.7% |
| Q4 2016 | $842,000 | – | 10,154 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |